Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,000 | 2 | 55.4% |
| Unspecified | $2,500 | 1 | 23.1% |
| Travel and Lodging | $1,980 | 3 | 18.3% |
| Food and Beverage | $352.20 | 4 | 3.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $8,289 | 8 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $2,500 | 1 | $0 (2020) |
| ABIOMED | $43.12 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43.12 | 1 | ABIOMED ($43.12) |
| 2020 | $2,500 | 1 | Avanir Pharmaceuticals, Inc. ($2,500) |
| 2019 | $8,289 | 8 | Janssen Pharmaceuticals, Inc ($8,289) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $43.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2020 | Avanir Pharmaceuticals, Inc. | — | — | Cash or cash equivalent | $2,500.00 | Research |
| Study: AVA1407 Observational Study in IED | ||||||
| 12/27/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Neuroscience | ||||||
| 12/27/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Neuroscience | ||||||
| 12/27/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $964.56 | General |
| Category: Neuroscience | ||||||
| 12/27/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $926.07 | General |
| Category: Neuroscience | ||||||
| 12/27/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $171.72 | General |
| Category: Neuroscience | ||||||
| 12/27/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | Cash or cash equivalent | $89.72 | General |
| Category: Neuroscience | ||||||
| 12/27/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $87.26 | General |
| Category: Neuroscience | ||||||
| 12/27/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | Cash or cash equivalent | $50.10 | General |
| Category: Neuroscience | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| AVA1407 Observational Study in IED | Avanir Pharmaceuticals, Inc. | $2,500 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 101 | 208 | $77,415 | $18,433 |
| 2022 | 3 | 80 | 233 | $91,214 | $22,127 |
| 2021 | 2 | 68 | 217 | $76,276 | $21,514 |
| 2020 | 2 | 62 | 209 | $64,654 | $16,177 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 187 | $71,682 | $17,217 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 21 | $5,733 | $1,217 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 201 | $77,699 | $19,253 | 24.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $8,043 | $1,777 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 20 | $5,472 | $1,097 | 20.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 52 | 194 | $70,382 | $19,956 | 28.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 23 | $5,894 | $1,558 | 26.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 175 | $57,139 | $14,355 | 25.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 34 | $7,515 | $1,821 | 24.2% |
About Dr. Glenn Currier, MD
Dr. Glenn Currier, MD is a Psychiatry healthcare provider based in Portland, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194753012.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glenn Currier, MD has received a total of $10,833 in payments from pharmaceutical and medical device companies, with $43.12 received in 2024. These payments were reported across 10 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($6,000).
As a Medicare-enrolled provider, Currier has provided services to 311 Medicare beneficiaries, totaling 867 services with total Medicare billing of $78,250. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry, Psychiatry
- Location Portland, ME
- Active Since 06/29/2006
- Last Updated 07/21/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1194753012
Products in Payments
- SPRAVATO (Drug) $8,289
- Impella (Device) $43.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Portland
Dr. Alisha Moreland, M.d, M.D
Psychiatry — Payments: $20,000
Dr. Jonathan Horey, M.d, M.D
Psychiatry — Payments: $7,457
Samir Ishak, Md, MD
Psychiatry — Payments: $6,005
Nancy Phillips, Md, MD
Psychiatry — Payments: $4,944
Alfred Lewy, Md, MD
Psychiatry — Payments: $4,458
Anca-Maria Bejenaru, Md, MD
Psychiatry — Payments: $4,266